EIF4H and neoplasm: We evaluated the consequences of shRNA-mediated eIF4H depletion in A549 cells (lung carcinoma) and HeLa cells (cervical adenocarcinoma), by measuring drug-induced apoptosis, cell proliferation, migration and tumor growth.